| Date | Time | Source | Headline | Symbol | Company |
| 09/28/2015 | 5:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/28/2015 | 5:41PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/28/2015 | 5:37PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/28/2015 | 5:04PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/28/2015 | 4:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/24/2015 | 8:06AM | PR Newswire (US) | Stock Updates on Biotechnology -- Celgene, Ariad Pharma, ImmunoGen, BioDelivery Sciences Intl., and Esperion Therapeutics | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/15/2015 | 7:35AM | Business Wire | ARIAD Announces Full Enrollment in Phase 2 ALTA Trial of Brigatinib | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/10/2015 | 9:27AM | Edgar (US Regulatory) | Statement of Ownership (sc 13g) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/03/2015 | 4:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/01/2015 | 5:16PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 09/01/2015 | 5:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/28/2015 | 3:42PM | Dow Jones News | Baxalta in Talks to Buy Ariad -Bloomberg | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/21/2015 | 4:20PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/14/2015 | 1:46PM | PR Newswire (US) | SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Boar... | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/11/2015 | 4:59PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/10/2015 | 7:35AM | Business Wire | ARIAD Announces First Patient Treated in Phase 2 Dose-Ranging Optic Trial of Iclusig (Ponatinib) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/07/2015 | 6:35PM | Edgar (US Regulatory) | Quarterly Report (10-q) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/05/2015 | 7:44AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 08/05/2015 | 7:35AM | Business Wire | ARIAD Reports Second Quarter 2015 Financial Results and Progress on Strategic Objectives | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/29/2015 | 7:45AM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/29/2015 | 7:35AM | PR Newswire (US) | PDL BioPharma Completes Royalty Transaction with ARIAD Pharmaceuticals | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/29/2015 | 7:35AM | Business Wire | ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with PDL BioPharma | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/28/2015 | 5:03PM | Edgar (US Regulatory) | Confidential Treatment Order (ct Order) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/27/2015 | 4:40PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/24/2015 | 4:08PM | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/22/2015 | 7:35AM | Business Wire | ARIAD to Webcast Conference Call on Second Quarter 2015 Financial Results | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/16/2015 | 5:41PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/16/2015 | 5:35PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/16/2015 | 5:27PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |
| 07/16/2015 | 5:15PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ARIA | Ariad Pharmaceuticals, Inc. |